Tagged MRI and PET in severe CAD: Discrepancy between preoperative inotropic reserve and intramyocardial functional outcome after revascularization

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Mazzadi, Alejandro N ^a,b   Janier, Marc F ^a,b,c   Brossier, Benjamin ^d   André Fouët, Xavier ^c,d   Revel, Didier ^a,c,d   Croisille, Pierre ^a,c,d  

^a INSERM   (France)

^b Centre d'Exploration/Recherche Med   (France)

^c UNIVERSITÉ LYON 1   (France)

^d LOUIS PRADEL HOSPITAL   (France)

Author keywords

Dobutamine; Magnetic resonance imaging; Myocardial viability; Positron emission tomography

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE TRANSPORT; HEART PERFUSION; HUMAN; INOTROPISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVASCULARIZATION;

ADULT; AGED; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOBUTAMINE; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; POSITRON-EMISSION TOMOGRAPHY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 7244229909     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00263.2004     Document Type: Article

References (37)

1. Abbate A, Biondi-Zoccai GG, Baldi A, Trani C, Biasucci LM, and Vetrovec GW. The open-artery hypothesis: new clinical and pathophysiologic insights. Cardiology 100: 196-206, 2003.
2. 15O PET and factor analysis. J Nucl Med 42: 782-787, 2001.
3. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, and Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 14: 639-652, 1989.
4. Bogaert J, Maes A, Van de Werf F, Bosmans H, Herregods MC, Nuyts J, Desmet W, Mortelmans L, Marchal G, and Rademakers FE. Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular function. Circulation 99: 36-43, 1999.
5. Bogaert J and Rademakers FE. Regional nonuniformity of normal adult human left ventricle. Am J Physiol Heart Circ Physiol 280: H610-H620, 2001.
6. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, and Lorenz WJ. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38: 1614-1623, 1997.
7. Clarysse P, Han M, Croisille P, and Magnin IE. Exploratory analysis of the spatio-temporal deformation of the myocardium during systole from tagged MRI. IEEE Trans Biomed Eng 49: 1328-1339, 2002.
8. Croisille P. Myocardial viability assessed with tagged MRI. MAGMA 11: 47-48, 2000.
9. DeFronzo RA, Tobin JD, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
10. Dendale P, Franken PR, van der Wall EE, and de Roos A. Wall thickening at rest and contractile reserve early after myocardial infarction: correlation with myocardial perfusion and metabolism. Coron Artery Dis 8: 259-264, 1997.
11. Di Paola R, Bazin J, Aubry F, and Aurengo A, Cavailloles F, Herry JY, and Kahn E. Handling of dynamic sequences in nuclear medicine. IEEE Trans Nucl Sci 29: 1310-1321, 1982.
12. Gallagher KP, Matsuzaki M, Osakada G, Kemper WS, and Ross J Jr. Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res 52: 716-729, 1983.
13. Geskin G, Kramer CM, Rogers WJ, Theobald TM, Pakstis D, Hu YL, and Reichek N. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 98: 217-223, 1998.
14. Hendel RC, Jamil T, and Glover DK. Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol 10: 197-204, 2003.
15. Homans DC, Asinger R, Elsperger KJ, Erlien D, Sublett E, Mikell F, and Bache RJ. Regional function and perfusion at the lateral border of ischemic myocardium. Circulation 71: 1038-1047, 1985.
16. Janier M, Mazzadi A, Lionnet M, Frouin F, André-Fouët X, Cinotti L, Revel D, and Croisille P. Factor analysis of medical image sequences improves evaluation of first-pass MR imaging acquisitions for myocardial perfusion. Acad Radiol 9: 26-39, 2002.
17. Kramer CM, Malkowski MJ, Mankad S, Theobald TM, Pakstis DL, and Rogers WJ Jr. Magnetic resonance tagging and echocardiographic response to dobutamine and functional improvement after reperfused myocardial infarction. Am Heart J 143: 1046-1051, 2002.
18. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, and Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 36: 1835-1840, 2000.
19. Mazzadi AN, Croisille P, Andre-Fouet X, Fol S, Duisit J, Ovize M, Comar D, and Janier MF. Myocardial perfusion and glucose uptake coupling in CAD patients. Int J Card Imaging 19: 389-399, 2003.
20. Mazzadi AN, Janier MF, Brossier B, Andre-Fouet X, McFadden E, Revel D, and Croisille P. Dobutamine-tagged MRI for inotropic reserve assessment in severe CAD: relationship with PET findings. Am J Physiol Heart Circ Physiol 286: H1946-H1953, 2004.
21. Melon PG, de Landsheere CM, Degueldre C, Peters JL, Kulbertus HE, and Pierard LA. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. J Am Coll Cardiol 30: 1651-1659, 1997.
22. Miller RR, DeMaria AN, Amsterdam EA, Mailander MM, Zelis R, Lurie AJ, and Mason DT. Improvement of reduced left ventricular diastolic compliance in ischemic heart disease after successful coronary artery bypass surgery. Am J Cardiol 35: 11-16, 1975.
23. Pace L, Filardi PP, Cuocolo A, Prastaro M, Acampa W, Dellegrottaglie S, Storto G, Della Morte AM, Piscione F, Chiariello M, and Salvatore M. Diagnostic accuracy of low-dose dobutamine echocardiography in predicting post-revascularisation recovery of function in patients with chronic coronary artery disease: relationship to thallium-201 uptake. Eur J Nucl Med 28: 1616-1623, 2001.
24. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, and Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 79: 281-288, 1998.
25. Panza JA, Dilsizian V, Curiel RV, Unger EF, Laurienzo JM, and Kitsiou AN. Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 6: 487-494, 1999.
26. Pasquet A, Lauer MS, Williams MJ, Secknus MA, Lytle B, and Marwick TH. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of preoperative myocardial function, perfusion, and metabolism. Eur Heart J 21: 125-136, 2000.
27. Pasquet A, Williams MJ, Secknus MA, Zuchowski C, Lytle BW, and Marwick TH. Correlation of preoperative myocardial function, perfusion, and metabolism with postoperative function at rest and stress after bypass surgery in severe left ventricular dysfunction. Am J Cardiol 84: 58-64, 1999.
28. Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu CO, Weisfeldt ML, Weiss JL, and Shapiro EP. Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging. Circulation 89: 1174-1182, 1994.
29. Schinkel AF, Bax JJ, van Domburg R, Elhendy A, Valkema R, Vourvouri EC, Sozzi FB, Roelandt JR, and Poldermans D. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy. J Nucl Med 44: 127-133, 2003.
30. Shan K, Constantine G, Sivananthan M, and Flamm SD. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 109: 1328-1334, 2004.
31. Trent RJ, Waiter GD, Hillis GS, McKiddie FI, Redpath TW, and Walton S. Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart 83: 40-46, 2000.
32. Udelson JE, Bonow RO, and Dilsizian V. The historical and conceptual evolution of radionuclide assessment of myocardial viability. J Nucl Cardiol 11: 318-334, 2004.
33. Van Dijkman PR, Kuijpers DA, Blom BM, and van Herpen G. Dobutamine stress magnetic resonance imaging: a valuable method in the noninvasive diagnosis of ischemic heart disease. J Electrocardiol 35 Suppl: 57-59, 2002.
34. Vom Dahl J, Eitzman DT, al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, Kirsh MM, and Schwaiger M. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 90: 2356-2366, 1994.
35. Waldman LK, Nosan D, Villarreal F, and Covell JW. Relation between transmural deformation and local myofiber direction in canine left ventricle. Circ Res 63: 550-562, 1988.
36. Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E, and Nagel E. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 109: 2172-2174, 2004.
37. Zerhouni EA, Parish DM, Rogers WJ, Yang A, and Shapiro EP. Human heart: tagging with MR imaging - a method for noninvasive assessment of myocardial motion. Radiology 169: 59-63, 1988.